Enanta Pharmaceuticals (ENTA) Revenue by Year
Enanta Pharmaceuticals, Inc generated $65.3M in revenue in fiscal year 2025. This represents a decrease of 3.4% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $65.3M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Enanta Pharmaceuticals, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ENTA Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3M | $65.3M-3.4% | $67.6M-14.6% | $79.2M-8.1% | $86.2M-11.2% | $97.1M-20.7% | $122.5M-40.3% | $205.2M-0.7% | $206.6M+101.0% | $102.8M+16.5% | $88.3M-45.1% | $160.9M+237.0% | $47.7M+48.9% | $32.1M-23.1% | $41.7M-0.4% | $41.9M |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
ENTA Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Enanta Pharmaceuticals, Inc financials
Frequently Asked Questions
What was Enanta Pharmaceuticals, Inc's revenue in fiscal year 2025?
Enanta Pharmaceuticals, Inc generated $65.3M in revenue in fiscal year 2025.
How fast is Enanta Pharmaceuticals, Inc's revenue growing?
Enanta Pharmaceuticals, Inc (ENTA) revenue fell by 3.4% year over year, from $67.6M to $65.3M in fiscal year 2025.
What is Enanta Pharmaceuticals, Inc's revenue over the last twelve months?
Enanta Pharmaceuticals, Inc (ENTA) reported $65.3M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
How has Enanta Pharmaceuticals, Inc's revenue changed over the years?
Across the 15 fiscal years this page covers, Enanta Pharmaceuticals, Inc (ENTA) revenue went from $41.9M in fiscal year 2011 to $65.3M in fiscal year 2025.
What was Enanta Pharmaceuticals, Inc's revenue in the most recent quarter?
Enanta Pharmaceuticals, Inc (ENTA) reported $14.4M in revenue in Q3 2026. This represents a decrease of 21.6% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Enanta Pharmaceuticals, Inc (ENTA) reported on that line in every period on record.